Literature DB >> 22443691

Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.

Monica K Mann1, Avijit Ray, Sreemanti Basu, Christopher L Karp, Bonnie N Dittel.   

Abstract

A dual role of B cells in experimental autoimmune encephalomyelitis (EAE), the animal model of the human autoimmune disease multiple sclerosis (MS), has been established. In the first role, B cells contribute to the pathogenesis of EAE through the production of anti-myelin antibodies that contribute to demyelination. On the contrary, B cells have also been shown to have protective functions in that they play an essential role in the spontaneous recovery from EAE. In this review, we summarize studies conducted in a number of species demonstrating the conditions under which B cells are pathogenic in EAE. We also discuss the phenotype and anti-inflammatory mechanisms of regulatory B cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22443691      PMCID: PMC3639139          DOI: 10.3109/08916934.2012.665523

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  89 in total

1.  B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.

Authors:  Martin S Weber; Thomas Prod'homme; Juan C Patarroyo; Nicolas Molnarfi; Tara Karnezis; Klaus Lehmann-Horn; Dimitry M Danilenko; Jeffrey Eastham-Anderson; Anthony J Slavin; Christopher Linington; Claude C A Bernard; Flavius Martin; Scott S Zamvil
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

2.  The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement.

Authors:  S J Piddlesden; H Lassmann; F Zimprich; B P Morgan; C Linington
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

3.  The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages.

Authors:  A Van der Goes; M Kortekaas; K Hoekstra; C D Dijkstra; S Amor
Journal:  J Neuroimmunol       Date:  1999-11-01       Impact factor: 3.478

4.  Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice.

Authors:  W L Hazenbos; J E Gessner; F M Hofhuis; H Kuipers; D Meyer; I A Heijnen; R E Schmidt; M Sandor; P J Capel; M Daëron; J G van de Winkel; J S Verbeek
Journal:  Immunity       Date:  1996-08       Impact factor: 31.745

5.  Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system.

Authors:  S Jander; J Pohl; D D'Urso; C Gillen; G Stoll
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

6.  B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.

Authors:  P Hjelmström; A E Juedes; J Fjell; N H Ruddle
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

7.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

8.  Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis.

Authors:  D O Willenborg; S J Prowse
Journal:  J Neuroimmunol       Date:  1983-10       Impact factor: 3.478

9.  Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice.

Authors:  T Takai; M Ono; M Hikida; H Ohmori; J V Ravetch
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

10.  Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization.

Authors:  Diane Sewell; Zhu Qing; Emily Reinke; David Elliot; Joel Weinstock; Matyas Sandor; Zsuzsa Fabry
Journal:  Int Immunol       Date:  2003-01       Impact factor: 4.823

View more
  31 in total

1.  Inhibitors of myelination: ECM changes, CSPGs and PTPs.

Authors:  Danielle E Harlow; Wendy B Macklin
Journal:  Exp Neurol       Date:  2013-11-04       Impact factor: 5.330

2.  High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis.

Authors:  B Oxombre; C Lee-Chang; A Duhamel; M Toussaint; M Giroux; M Donnier-Maréchal; P Carato; D Lefranc; H Zéphir; L Prin; P Melnyk; P Vermersch
Journal:  Br J Pharmacol       Date:  2015-02-10       Impact factor: 8.739

Review 3.  The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.

Authors:  Sandra M Cardona; Jenny A Garcia; Astrid E Cardona
Journal:  Methods Mol Biol       Date:  2013

4.  Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation.

Authors:  Sheng Xiao; Craig R Brooks; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Immunol       Date:  2015-01-12       Impact factor: 5.422

5.  Anti-CD48 Monoclonal Antibody Attenuates Experimental Autoimmune Encephalomyelitis by Limiting the Number of Pathogenic CD4+ T Cells.

Authors:  Shannon L McArdel; Daniel R Brown; Raymond A Sobel; Arlene H Sharpe
Journal:  J Immunol       Date:  2016-08-31       Impact factor: 5.422

6.  Neurotoxic or Neuroprotective? Current Controversies in SCI-Induced Autoimmunity.

Authors:  Jonah W Saltzman; Ricardo Battaglino; Helen Stott; Leslie R Morse
Journal:  Curr Phys Med Rehabil Rep       Date:  2013-09

7.  Cutting Edge: Integrin α4 Is Required for Regulatory B Cell Control of Experimental Autoimmune Encephalomyelitis.

Authors:  Simon Glatigny; Catriona A Wagner; Estelle Bettelli
Journal:  J Immunol       Date:  2016-03-25       Impact factor: 5.422

8.  Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function.

Authors:  Peter T Sage; Frank A Schildberg; Raymond A Sobel; Vijay K Kuchroo; Gordon J Freeman; Arlene H Sharpe
Journal:  J Immunol       Date:  2018-03-12       Impact factor: 5.422

9.  IL7Rα contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineages.

Authors:  Jessica J Ashbaugh; Roberta Brambilla; Shaffiat A Karmally; Cecilia Cabello; Thomas R Malek; John R Bethea
Journal:  J Immunol       Date:  2013-03-25       Impact factor: 5.422

10.  Increased circulating interleukin 10-secreting B cells in patients with dilated cardiomyopathy.

Authors:  Yujie Guo; Zhihong Cen; Bin Wei; Weifeng Wu; Qiuxi Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.